Home > News & Activities > Latest News

Latest News

Information of Truvada and Atripla delisting

From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). In addition, from October 2020 Atripla will be delisted. We encourage you to talk to your prescribing doctor further regarding generic equivalent/s of both antiretrovirals (ARVs) that are available.

Job Opportunity: Resources Project Officer

NAPWHA is looking for a Resources Project Officer to join our dynamic team working from Newtown, Sydney and deliver two exciting education projects in 2020. Applications must be received by 4.00pm Thursday 9 April 2020 (AEST).

CROI 2020 Report Back

This CROI (Conference on Retroviruses and Opportunistic Infections) report back has been provided by NAPWHA Senior Research Manager, Dr John Rule, who has selected some snippets of information, curated for our NAPWHA member organisations and our Treatment Officer Network.

Events marking the National Day of Women Living with HIV 2020

NAPWHA and the National Network of Women Living with HIV known as Femfatales had the honour of hosting a dinner and one-day forum in Sydney to mark the 5th National day of Women living with HIV (#NDWLHIV). It was a valuable opportunity for women to join together and hear from other leaders in the sector and plot a course forward to better engage with and deliver for all women living with HIV in Australia.

Share This